BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37329999)

  • 1. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease.
    Yang X; Chen Z; Luo Z; Yang D; Hao Y; Hu J; Feng J; Zhu Z; Luo Q; Zhang Z; Liang W; Ding G
    Cell Signal; 2023 Sep; 109():110777. PubMed ID: 37329999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-10 negatively regulates inflammation in diabetic kidney via targeting activation of the NLRP3 inflammasome.
    Ding H; Li J; Li Y; Yang M; Nie S; Zhou M; Zhou Z; Yang X; Liu Y; Hou FF
    Mol Ther; 2021 Jul; 29(7):2308-2320. PubMed ID: 33744467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
    Kim D; Ban KY; Lee GH; Jun HS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
    Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
    Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W; Liu BH; Wan YG; Sun W; Liu YL; Wang WW; Fang QJ; Tu Y; Yee HY; Yuan CC; Wan ZY
    Zhongguo Zhong Yao Za Zhi; 2019 Dec; 44(24):5457-5464. PubMed ID: 32237395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
    Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
    Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L; Ding M; Chen F; Zhu D; Xie X
    PeerJ; 2023; 11():e14826. PubMed ID: 36815984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease
    Wang MZ; Wang J; Cao DW; Tu Y; Liu BH; Yuan CC; Li H; Fang QJ; Chen JX; Fu Y; Wan BY; Wan ZY; Wan YG; Wu GW
    Front Pharmacol; 2022; 13():790937. PubMed ID: 35370636
    [No Abstract]   [Full Text] [Related]  

  • 11. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation.
    Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 17. Total Flavones of
    Liu BH; Tu Y; Ni GX; Yan J; Yue L; Li ZL; Wu JJ; Cao YT; Wan ZY; Sun W; Wan YG
    Front Pharmacol; 2021; 12():667644. PubMed ID: 34335245
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
    Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome.
    Xiao Y; Zhao C; Tai Y; Li B; Lan T; Lai E; Dai W; Guo Y; Gan C; Kostallari E; Tang C; Gao J
    Redox Biol; 2023 Jun; 62():102691. PubMed ID: 37018971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.